These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33216064)

  • 1. Molecular Biomarkers: A Review of Multiple Applications in Clinical Care of Colorectal Cancer.
    Schmitt ML
    Clin J Oncol Nurs; 2020 Dec; 24(6):635-643. PubMed ID: 33216064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
    Molloy MP; Engel A
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786
    [No Abstract]   [Full Text] [Related]  

  • 3. Precision medicine for metastatic colorectal cancer: an evolving era.
    Guler I; Askan G; Klostergaard J; Sahin IH
    Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):919-931. PubMed ID: 31475851
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrating Biomarkers and Targeted Therapy Into Colorectal Cancer Management.
    Lieu CH; Corcoran RB; Overman MJ
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():207-215. PubMed ID: 31099678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
    Lin PS; Semrad TJ
    Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of biomarkers to guide the treatment of metastatic colorectal cancer.
    Davis LE
    Am J Manag Care; 2018 Apr; 24(7 Suppl):S107-S117. PubMed ID: 30207665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker-guided therapy for colorectal cancer: strength in complexity.
    Sveen A; Kopetz S; Lothe RA
    Nat Rev Clin Oncol; 2020 Jan; 17(1):11-32. PubMed ID: 31289352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in Colorectal Cancer.
    Yiu AJ; Yiu CY
    Anticancer Res; 2016 Mar; 36(3):1093-102. PubMed ID: 26977004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology.
    Corti G; Bartolini A; Crisafulli G; Novara L; Rospo G; Montone M; Negrino C; Mussolin B; Buscarino M; Isella C; Barault L; Siravegna G; Siena S; Marsoni S; Di Nicolantonio F; Medico E; Bardelli A
    Clin Colorectal Cancer; 2019 Jun; 18(2):91-101.e3. PubMed ID: 30981604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
    Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
    World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.
    Włodarczyk M; Włodarczyk J; Siwiński P; Sobolewska-Włodarczyk A; Fichna J
    Curr Drug Targets; 2018; 19(15):1731-1737. PubMed ID: 30073926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent applications of chemosensitivity tests for colorectal cancer treatment.
    Yoon YS; Kim JC
    World J Gastroenterol; 2014 Nov; 20(44):16398-408. PubMed ID: 25469008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances.
    Lech G; Słotwiński R; Słodkowski M; Krasnodębski IW
    World J Gastroenterol; 2016 Feb; 22(5):1745-55. PubMed ID: 26855534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer.
    Kelley RK; Van Bebber SL; Phillips KA; Venook AP
    J Natl Compr Canc Netw; 2011 Jan; 9(1):13-25. PubMed ID: 21233242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive response factors in colorectal cancer patients: between hope and reality.
    De Divitiis C; Nasti G; Montano M; Fisichella R; Iaffaioli RV; Berretta M
    World J Gastroenterol; 2014 Nov; 20(41):15049-59. PubMed ID: 25386053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF mutations in colorectal cancer: clinical relevance and role in targeted therapy.
    Yaeger R; Saltz L
    J Natl Compr Canc Netw; 2012 Nov; 10(11):1456-8. PubMed ID: 23138171
    [No Abstract]   [Full Text] [Related]  

  • 17. Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer.
    Kim SY; Kim TW
    ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32188714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and evolving biomarkers for precision oncology in the management of metastatic colorectal cancer.
    Henry JT; Johnson B
    Chin Clin Oncol; 2019 Oct; 8(5):49. PubMed ID: 31500426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.
    Mohapatra SS; Batra SK; Bharadwaj S; Bouvet M; Cosman B; Goel A; Jogunoori W; Kelley MJ; Mishra L; Mishra B; Mohapatra S; Patel B; Pisegna JR; Raufman JP; Rao S; Roy H; Scheuner M; Singh S; Vidyarthi G; White J
    Dig Dis Sci; 2018 May; 63(5):1123-1138. PubMed ID: 29572615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine.
    Gatalica Z; Vranic S; Xiu J; Swensen J; Reddy S
    Fam Cancer; 2016 Jul; 15(3):405-12. PubMed ID: 26875156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.